OSF
open access
The Psychology of GLP-1 Receptor Agonists: Evidence for Distinct Effects on Reward, Interoception and Cognition
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for obesity and type 2 diabetes, supporting weight loss and glycaemic control through effects on appetite and ingestive behaviour. The psychobiological mechanisms underlying these effects remain unclear. We reviewed evidence for c
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health#808149
- The Quiet Window–Challenge Window Framework: A Conceptual Framework for Habit Formation During GLP-1 Receptor Agonist Therapy#976849
- The Quiet Window–Challenge Window Framework: A Conceptual Framework for Habit Formation During GLP-1 Receptor Agonist Therapy#976676
- GLP-1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms.#1330065
- GLP-1 receptor agonist use is associated with shorter survival in patients with amyotrophic lateral sclerosis and diabetes mellitus#1181784
Record · ID 1360396
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive